DC
HAE icon

Deere & Company’s Haemonetics HAE Stock Holding History

Deere & Company’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-7,060
Closed -$256K – 317
2016
Q3 		$256K Hold
7,060
– – 0.01% 910
2016
Q2 		$205K Sell
7,060
-11,977
-63% -$362K 0.01% 963
2016
Q1 		$666K Buy
+19,037
New +$615K 0.04% 478
2015
Q2 		– Sell
-5,786
Closed -$260K – 1041
2015
Q1 		$260K Hold
5,786
– – 0.01% 788
2014
Q4 		$217K Hold
5,786
– – 0.01% 843
2014
Q3 		$202K Buy
+5,786
New +$206K 0.01% 876

Other funds holding HAE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's HAE Position: Q4 2016 in Review

Deere & Company sold out of Haemonetics (HAE) in Q4 2016, closing a stake of 7,060 shares — an estimated $256K sold.

Deere & Company first reported a position in HAE in Q3 2014 and held it in 6 quarters. The position peaked at $666K in Q1 2016. 198 funds tracked by Wall St. Rank hold HAE as of Q4 2016.

  • Deere & Company reported no remaining Haemonetics position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 7,060 Haemonetics shares in Q4 2016, an estimated $256K.
  • Deere & Company first reported a position in Haemonetics in Q3 2014 and held it in 6 quarters.
  • Deere & Company's Haemonetics position peaked at $666K in Q1 2016.
  • 198 funds tracked by Wall St. Rank held Haemonetics as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.